Non-Invasive Glucose-Monitoring Market Trends

Growth Drivers

• Shift towards home-based care: In the face of a global desire to attain better medical access for all of humanity, organizations are providing devices that are intended to be used without needing medical supervision. A shift to home-based care is increasing demand for the non-invasive glucose monitoring devices segment of the market. The expansion of Telehealth and remote patient monitoring technologies has also justified the demand for accurate home-based glucose monitoring products that can integrate with smartphones and cloud-based programmes. The need for accuracy will lower healthcare costs, omit clinic visits, and present another opportunity for better disease management by sharing data with healthcare professionals. Moreover, with demand for non-invasive glucose monitors increased by home-based care models, there is now no doubt that monitoring products represent an important measure for modern chronic disease management.
• Regulatory support in terms of technological innovations: There has been constant support from the governing bodies, which readily encourages manufacturers involved in the non-invasive glucose monitoring devices market to develop accessible devices. Regulatory agencies, including the FDA and CE, are implementing more flexible and faster approval pathways for innovative medical devices for devices that demonstrate safety and efficacy. This support encourages manufacturers to invest in innovative research so they can market sustainable and client-friendly products. Regulatory incentives, paired with collaboration with innovators, help reduce some of the many barriers related to delays of regulatory approvals and associated costs dramatically. This facilitates new diabetes solutions that make available non-invasive glucose monitors that meet the needs of the real world.
• Advancements in technology and integration: Advances in sensor design, optics, and artificial intelligence have recently made non-invasive glucose monitors more convenient and accurate. Devices utilize state-of-the-art technology in wearable sensors, interface with smartphones, and drive cloud connections to enable real-time glucose data and actionable insights at the user’s fingertips. AI analytics can help to predict trends in glucose responses and to offer advice specific to the patient’s pattern throughout the day, enhancing disease management. The continual macro and micro changes in devices, including miniaturizing devices and improved battery life, also create a user experience that enhances accessibility. Increasingly, it is also potential non-diabetic purchasers, who are looking after their own health concerns about BMI, obesity, or associated discomfort due to limited movement, that are encouraging new users to join the market outside of a traditional delineation.

Challenge

• Limited awareness: Despite continuous and rigorous innovations in the non-invasive glucose monitoring devices market, there is limited awareness and education regarding these advanced devices. In this regard, an initiative must be undertaken by the healthcare providers to offer education in terms of the benefits offered by non-invasive glucose monitors. Lack of proper knowledge diminishes the consumer interest in leveraging at-home glucose monitoring, thereby hindering growth in the market.
• Regulatory hurdles: Due to strict safety and accuracy requirements from regulatory bodies like the FDA and CE, obtaining regulatory approval for non-invasive glucose monitors is no easy task. A number of devices are still in clinical trials or have limited approval from the FDA and CE. The approval process is draining and costly, and will take time to collect enough data to convince regulatory bodies that there is evidence that a non-invasive device's accuracy is equivalent or superior to existing device. This counteracts the expedient manner by which the clinical market could enter, and the ability to commercialize a device.